# Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal Cancer

> **NCT01648894** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 265 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **PROCEDURE:** Surgery after 11 weeks of delay after chemoradiotherapy.
- **PROCEDURE:** Surgery after 7 weeks of delay after chemoradiotherapy

## Key facts

- **NCT ID:** NCT01648894
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-25
- **Primary completion:** 2015-10-22
- **Final completion:** 2020-05-06
- **Target enrollment:** 265 (ACTUAL)
- **Last updated:** 2022-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01648894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01648894, "Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01648894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*